The Influence of Immune Heterogeneity on the Effectiveness of Immune Checkpoint Inhibitors in Multifocal Hepatocellular Carcinomas.
Huang M, He M, Guo Y, Li H, Shen S, Xie Y, Li X, Xiao H, Fang L, Li D, Peng B, Liang L, Yu J, Kuang M, Xu L, Peng S.
Huang M, et al. Among authors: guo y.
Clin Cancer Res. 2020 Sep 15;26(18):4947-4957. doi: 10.1158/1078-0432.CCR-19-3840. Epub 2020 Jun 11.
Clin Cancer Res. 2020.
PMID: 32527942